10 Best Articles on Biotech
The most useful articles on biotech from around the web—beginners to advanced—curated by thought leaders and our community. We focus on timeless pieces and update the list whenever we discover new, must-read articles or videos—make sure to bookmark and revisit this page.
Top 5 Biotech Articles
At a glance: these are the articles that have been most read, shared, and saved on biotech by Refind users in 2023 so far.
- Doctors have performed brain surgery on a fetus in one of the first operations of its kind
- Here’s why we’re not prepared for the next wave of biotech innovation
- How scientists want to make you young again
- Inside the billion-dollar meeting for the mega-rich who want to live forever
- How your brain data could be used against you
Trending
These links are currently making the rounds on biotech on Refind.
Doctors have performed brain surgery on a fetus in one of the first operations of its kind
A baby girl who developed a life-threatening brain condition was successfully treated before she was born—and is now a healthy seven-week-old.
Short Articles
Short on time? Check out these useful short articles on biotech—all under 10 minutes.
How your brain data could be used against you
Brain stimulation technologies are on the rise. And so is the risk of losing our brain privacy.
The Future of Fertility
A new crop of biotech startups want to revolutionize human reproduction.
Roboticists Want to Give You a Third Arm
Unused bandwidth in neurons can be tapped to control extra limbs
Crispr Wants to Feed the World
The power to fight human diseases put genome editing on the map. But similar technology could help crops withstand the stress of climate change.
Inside the billion-dollar meeting for the mega-rich who want to live forever
Hope, hype, and self-experimentation collided at an exclusive conference for ultra-rich investors who want to extend their lives past 100. I went along for the ride.
Long Articles
These are some of the most-read long-form articles on biotech.
Here’s why we’re not prepared for the next wave of biotech innovation
This is "biology's century," @matthewherper writes. But we’re approaching a moment when changes in what we understand are every bit as terrifying as exhilarating.
Deal or Die: Your 3-Part Guide to Business Development in TechBio
Making deals in TechBio is about forging authentic relationships. That's why today we're releasing our guide to building that network early.
How scientists want to make you young again
Research labs are pursuing technology to “reprogram” aging bodies back to youth.
Techbio Taxonomy
A guest post by Elliot Hershberg on the four forces reshaping biotech startups
Publications
We monitor hundreds of publications, blogs, newsletters, and news sources in Biotech, including:
MIT Technology Review
Our in-depth reporting on innovation reveals and explains what’s really happening now to help you know what’s coming next. http://technologyreview.com/newsletters
Singularity Hub
Chronicling technological progress in AI, robotics, health, & exponential tech. By @singularityu.
a16z
we invest in software eating the world http://a16z.com/portfolio/ http://a16z.com/podcasts/ Check out our AI Canon: https://a16z.com/2023/05/25/ai-canon/
Labiotech.eu
Reporting on innovations in global biotech.
Packy McCormick
Boyboss @ Not Boring: http://notboring.co || Not Boring Capital || Advisor @a16z crypto
What is Refind?
Every day Refind picks the most relevant links from around the web for you. Picking only a handful of links means focusing on what’s relevant and useful. We favor timeless pieces—links with long shelf-lives, articles that are still relevant one month, one year, or even ten years from now. These lists of the best resources on any topic are the result of years of careful curation.
How does Refind curate?
It’s a mix of human and algorithmic curation, following a number of steps:
- We monitor 10k+ sources and 1k+ thought leaders on hundreds of topics—publications, blogs, news sites, newsletters, Substack, Medium, Twitter, etc.
- In addition, our users save links from around the web using our Save buttons and our extensions.
- Our algorithm processes 100k+ new links every day and uses external signals to find the most relevant ones, focusing on timeless pieces.
- Our community of active users gets the most relevant links every day, tailored to their interests. They provide feedback via implicit and explicit signals: open, read, listen, share, mark as read, read later, «More/less like this», etc.
- Our algorithm uses these internal signals to refine the selection.
- In addition, we have expert curators who manually curate niche topics.
The result: lists of the best and most useful articles on hundreds of topics.
How does Refind detect «timeless» pieces?
We focus on pieces with long shelf-lives—not news. We determine «timelessness» via a number of metrics, for example, the consumption pattern of links over time.
How many sources does Refind monitor?
We monitor 10k+ content sources on hundreds of topics—publications, blogs, news sites, newsletters, Substack, Medium, Twitter, etc.
Which sources does Refind monitor on biotech?
We monitor hundreds of sources on biotech, including MIT Technology Review, Singularity Hub, a16z, Labiotech.eu, Packy McCormick, and many more.
Can I submit a link?
Indirectly, by using Refind and saving links from outside (e.g., via our extensions).
How can I report a problem?
When you’re logged-in, you can flag any link via the «More» (...) menu. You can also report problems via email to hello@refind.com
Who uses Refind?
200k+ smart people start their day with Refind. To learn something new. To get inspired. To move forward. Our apps have a 4.9/5 rating.
Is Refind free?
Yes, it’s free!
How can I sign up?
Head over to our homepage and sign up by email or with your Twitter or Google account.